Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Lexaria Bioscience Corp. (LEXX) had Non-Operating Income/Expense of $-0.04M for the most recently reported fiscal quarter, ending 2025-05-31.
| Income Statement Financials | |
$0.17M |
|
$-3.79M |
|
-- |
|
$0.17M |
|
$3.92M |
|
$-3.75M |
|
|
Non-Operating Income/Expense |
$-0.04M |
$-3.79M |
|
$-3.75M |
|
$-3.79M |
|
$-3.79M |
|
$-3.79M |
|
$-3.75M |
|
$-3.75M |
|
$-3.72M |
|
18.30M |
|
18.30M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$5.81M |
|
$0.24M |
|
$0.93M |
|
$6.74M |
|
$1.49M |
|
-- |
|
$0.09M |
|
$1.57M |
|
$5.17M |
|
$4.65M |
|
$5.17M |
|
19.56M |
|
| Cash Flow Statement Financials | |
$-7.81M |
|
$-0.09M |
|
$6.05M |
|
$6.50M |
|
$4.59M |
|
$-1.91M |
|
$0.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2155.41% |
|
-2155.41% |
|
-- |
|
-2178.51% |
|
-2177.64% |
|
$-7.83M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.49 |
|
185.24 |
|
-73.37% |
|
-81.52% |
|
-56.23% |
|
-73.37% |
|
$0.26 |
|
$-0.43 |
|
$-0.43 |
|